ASM Microbe 2018: Summit Therapeutics unveils second novel target for gonorrhea
At ASM Microbe (7–11 June, 2018), Summit Therapeutics announced the discovery of a second novel drug target to treat gonorrhea infection, highlighting the power of the Discuva platform.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.